D.M. Tschaen - Concepedia

Author

D.M. Tschaen

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

D. M. TSCHAEN, D.M. Tschaen, Dave Tschaen, Tschaen, D.M.

Publications

153

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

D.M. Tschaen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, molecular pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	54
2	Engineering	1	1	21
3	Natural Sciences	1	1	33
4	Biochemistry	1	1	33
5	Biomolecular Engineering	1	1	21

D.M. Tschaen

Publications

152

Citations

H-Index

Page 1

	Year	Citations
An efficient synthesis of 4-benzoyloxyazetidinone: an important carbapenem intermediate D.M. Tschaen, L. M. FUENTES, Joseph E. Lynch, Tetrahedron Letters Organic ChemistryEfficient SynthesisChemistryHeterocycle ChemistryPharmacology	1988	53
Methods for the Synthesis of 5,6,7,8-Tetrahydro-1,8-naphthyridine Fragments for α<sub>V</sub>β<sub>3</sub> Integrin Antagonists Frederick W. Hartner, Yi Hsiao, Kan K. Eng, The Journal of Organic Chemistry	2004	45
Enantioselective Preparation of Ring-Fused 1-Fluorocyclopropane-1-carboxylate Derivatives: En Route to mGluR 2 Receptor Agonist MGS0028 Fei Zhang, Zhiguo J. Song, D.M. Tschaen, Organic Letters Molecular PharmacologyMedicinal ChemistryReceptor Agonist Mgs0028Enantioselective PreparationBiochemistry	2004	33
Practical Synthesis of a Neuropeptide Y Antagonist via Stereoselective Addition to a Ketene Takehiko Iida, Hiroki Satoh, Kenji Maeda, The Journal of Organic Chemistry EngineeringOrganic ChemistryPeptide ScienceStereoselective AdditionMolecular Pharmacology	2005	21

Page 1